Stacy Croteau
Pediatric Hematology-Oncology · Boston, MANPI 1831358993
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $80,962 of the $116,514 with a category attached, or 69.5%. It is spread thinly across 14 manufacturers, the largest accounting for just 15.9%. Among pediatric hematology-oncology clinicians in MA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 77 payments — averaging $1513.17 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Sanofi$19K
- Sanofi-aventis U.S. LLC$16K
- Bayer$14K
- Biomarin Pharmaceutical Inc.$12K
- Pfizer$12K
- Novo Nordisk$11K
- plus $33K from 8 others
Across 101 payments — averaging $5058.17 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Spark Therapeutics, Inc.$182K
- Novo Nordisk AS$98K
- Sanofi US Services Inc.$71K
- Pfizer$54K
- Genentech, Inc.$42K
- Boehringer Ingelheim$37K
- plus $27K from 4 others
What the payments were for
- Consulting fees$80,96269%
- Speaking & faculty fees$25,80222%
- Travel & lodging$3,0713%
- Food & beverage$1,4341%
- Education$5,2445%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Sanofi | 12 | $18,545 |
| Sanofi-aventis U.S. LLC | 7 | $16,234 |
| Bayer | 3 | $14,067 |
| Biomarin Pharmaceutical Inc. | 10 | $12,394 |
| Pfizer | 8 | $11,942 |
| Novo Nordisk | 4 | $10,585 |
| Shire North American Group Inc | 2 | $10,167 |
| Genentech USA, Inc. | 6 | $8,410 |
| Spark Therapeutics, Inc. | 14 | $5,162 |
| CSL Behring | 1 | $4,120 |
| Novo Nordisk Health Care AG | 1 | $2,700 |
| F. Hoffmann-la Roche AG | 4 | $1,482 |
| Octapharma USA, Inc. | 2 | $557 |
| Genentech, Inc. | 3 | $150 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$116,514 in reported general payments places this provider in the 95th percentile of 114 pediatric hematology-oncology providers in Massachusetts.
See all pediatric hematology-oncology providers in Massachusetts →
Other pediatric hematology-oncology in Boston
- Leslie KeanBoston$558K
- Todd GolubBoston$213K
- Rachael GraceBoston$201K
- Matthew HeeneyBoston$101K
- Susan PerrineBoston$96K
- Christine DuncanBoston$89K
- Eric GrabowskiBoston$56K
- Derek HansonBoston$54K
- Susan ParsonsBoston$47K
- Karen BrideBoston$47K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.